Trademarkia Logo

Canada

C$
Trademark Search in Canada
SEMAPHORE

View On IC.GC.CA

SEMAPHORE
SEARCHED

on 7 Jun 2023

Last Applicant/ Owned by

Otolanum AG

Bahnhofstrasse 21CH-6300 Zug

CH

Serial Number

2165542 filed on 2th Dec 2021

Correspondent Address

KIRBY EADES GALE BAKER

55 Murray StreetSuite 300Ottawa

ONTARIO

CA

K1N5M3

SEMAPHORE

Trademark usage description

pharmaceutical preparations, namely, therapeutics comprising nucleic acids, peptides and proteins for use in the intracellular treatment or prevention Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, therapeutics comprising nucleic acids, peptides and proteins for use in the intracellular treatment or prevention of allergy, autoimmune, cardiovascular, dermatologic, endocrine, gastroenterological, hematologic, immunologic, infectious, metabolic, neurological, oncologic, ophthalmologic, orthopedic, pain, pulmonary, psychiatric, mental health, respiratory, urologic, and eye diseases and conditions, rheumatism, rheumatosis, rheumatic pain, muscle sprains, bruises; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for use in the treatment of autoinflammatory diseases; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries, pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; preparations for the diagnosis and treatment of disorders relating to sexual reproduction and fertility; pharmaceutical preparations, namely, human and veterinary vaccines comprising nucleic acids, peptides and proteins for use in the intracellular treatment and prevention of diseases and disorders

Classification kind code

11

Class [042]
Scientific research in the fields of pharmacology, pharmaceuticals, and biochemistry, namely, scientific research in the fields of therapeutics and vaccines comprising nucleic acids, peptides and proteins for use in the intracellular treatment and prevention of diseases and disorders

Classification kind code

11

Mark Details

Serial Number

2165542

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 30th Aug 2023		Agent Changed
Submitted for opposition 22
on 7th Jun 2023		Search Recorded
Submitted for opposition 20
on 7th Jun 2023		Examiner's First Report
Submitted for opposition 223
on 7th Jun 2023		Total Provisional Refusal
Submitted for opposition 256
on 12th Dec 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 10th Feb 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 9th Feb 2022		Created
Submitted for opposition 31
on 9th Feb 2022		Formalized
Submitted for opposition 30
on 2th Dec 2021		Filed
Submitted for opposition 228
on 2th Dec 2021		International Registration